These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fasting and postprandial serum gastrin levels in obese and slim subjects, and the effects of surgical treatment for obesity on serum gastrin levels. Amland PF; Jorde R; Giercksky KE; Kildebo S; Burhol PG Acta Chir Scand; 1984; 150(3):223-8. PubMed ID: 6464625 [TBL] [Abstract][Full Text] [Related]
6. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Sarson DL; Scopinaro N; Bloom SR Int J Obes; 1981; 5(5):471-80. PubMed ID: 6796532 [TBL] [Abstract][Full Text] [Related]
7. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux-en-Y gastric bypass versus after colectomy: a prospective comparative study. Stratis C; Alexandrides T; Vagenas K; Kalfarentzos F Obes Surg; 2006 Jun; 16(6):752-8. PubMed ID: 16756737 [TBL] [Abstract][Full Text] [Related]
8. Serum gastrin concentrations in healthy people of the various ABO blood groups. Melissinos K; Alegakis G; Archimandritis AJ; Theodoropoulos G Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):482-6. PubMed ID: 726818 [TBL] [Abstract][Full Text] [Related]
9. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062 [TBL] [Abstract][Full Text] [Related]
11. [Intestinal transit time in bilio-pancreatic bypass]. Bonalumi U; Moresco L; Gianetta E; Civalleri D; De Cata T; Brignole E; Scopinaro N Minerva Chir; 1980 Jul 15-31; 35(13-14):993-6. PubMed ID: 6779238 [TBL] [Abstract][Full Text] [Related]
12. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Skroubis G; Sakellaropoulos G; Pouggouras K; Mead N; Nikiforidis G; Kalfarentzos F Obes Surg; 2002 Aug; 12(4):551-8. PubMed ID: 12194550 [TBL] [Abstract][Full Text] [Related]
13. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Regan JP; Inabnet WB; Gagner M; Pomp A Obes Surg; 2003 Dec; 13(6):861-4. PubMed ID: 14738671 [TBL] [Abstract][Full Text] [Related]
14. Proceedings: Gastrin response to a standard meal after jejuno-ileal bypass in morbid obese patients. Lennon J; Lipgard GP; Terry SH; Sircus W Gut; 1975 May; 16(5):407. PubMed ID: 1140685 [No Abstract] [Full Text] [Related]
15. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
17. Gastrin and gastric acid secretion in hepaticojejunostomy Roux-en-Y. Nielsen ML; Jensen SL; Malmstrøm J; Nielsen OV Surg Gynecol Obstet; 1980 Jan; 150(1):61-4. PubMed ID: 7350704 [TBL] [Abstract][Full Text] [Related]
18. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Lin E; Gletsu N; Fugate K; McClusky D; Gu LH; Zhu JL; Ramshaw BJ; Papanicolaou DA; Ziegler TR; Smith CD Arch Surg; 2004 Jul; 139(7):780-4. PubMed ID: 15249413 [TBL] [Abstract][Full Text] [Related]